Some authors have suggested that spontaneous MxA mRNA levels in MS patients may be useful to identify patients with active disease forms [24] and those experiencing a relapse [25].They found that higher baseline MxA mRNA levels are related to a longer time to a new relapse. Here, MX1 is linked to myeloid sarcoma.